A study of the effect of neoadjuvant chemotherapy with FAC regime in locally advanced breast carcinoma

Ajesh Gopal, U. Anjit

Abstract


Background: Cases of carcinoma breast with TNM stage 3 are considered as locally advanced breast cancer. This study was done to demonstrate the effect of neoadjuvant chemotherapy in cases of stage 3 technically inoperable breast cancers. As neoadjuvant chemotherapy is an already established form of treatment, its effect on ‘complete clinical response and pathological response’ were studied.

Methods: This prospective study was carried out in department of general surgery of Medical college, Thiruvananthapuram after obtaining approval from research ethical committee. Relevant data of chemotherapy was collected from department of Radiotherapy and Histopathological data was collected from department of Pathology. 25 cases of locally advanced breast carcinoma were studied. These patients were started on treatment with FAC regime and the response was assessed.

Results: In this study 20% of patients had complete clinical response at the completion of 3 cycles of chemotherapy with FAC regime. 48% had partial response. In 32% of patients, stasis was observed. None showed increase in tumor size during treatment.

Conclusion: The study demonstrated the effectiveness of neoadjuvant chemotherapy in downstaging the tumor enabling definitive surgery with less morbidity. It also showed a complete clinical and pathological response in a significant number of patients.

 


Keywords


LABC, FAC regime, Chemotherapy

Full Text:

PDF

References


J Dirk Iglehart, Barbara L. Smith; Sabiston text book of surgery. The Biological basis of Modern surgical Practice. 18th edition 2008, Vol - 1, 868.

Barry W. Feig, David H Berger, George M. Fuhrman- MD Andersons surgical oncology handbook, 4th edition 2006; 42.

F. Charles Brunicardi, Dana K. Andersen, Thimothy R. Billiar, David L. Dunn, John G. Hunter, Raphel E. Pollock. Schwartz Principles of surgery 8th 2005 - part 2 - 16; 492.

M Thompson, S. L Moulder Thompson; Annals of Oncology, Vol 23-2012, supplement 10; 23I.

Abigail S. Caudle et al, Predictors of tumour progression during neoadjuvant chemotherapy in breast cancer, Journal of Clinical oncology 2010; 1825.

Fisher B, Gunduz N, Coyle J, Rudock C, Saffer E. Presence of a growth stimulating factor in serum following primary tumour removal in mice. Cancer Res 1989; 49:1996 - 2001.

David Mauri, Nicolas Pavlidis, John P. A. Ioannidis. Neoadjuvant versus Adjuvant Systemic Treatment in Breast Cancer: A Meta Analysis, JNCI, Vol. 97, No.3, 2005.